Vertanical launches medical cannabis Exilby in Europe
medical cannabis Exilby launches in Germany and Austria after EU approval for chronic low back pain. FDA Breakthrough granted; US Phase 3 trial of 810
Cannabis news, weed news, marijuana news
medical cannabis Exilby launches in Germany and Austria after EU approval for chronic low back pain. FDA Breakthrough granted; US Phase 3 trial of 810
Wake Forest-backed Winston-Salem seeks medical cannabis research role, surveys centuries of therapeutic use, FDA cannabinoid drugs, and federal barriers.
medical cannabis prescriptions in London rose 105% from 179 in 2021 to 368 in 2025. UK issued 4,204 NHS cannabis medicine scripts in 2025; Sativex made up
medical cannabis patient accounts shift UK views. Releaf survey of 1,669 shows 97% report better quality of life; stories increase disclosure and family
cannabis painkiller Exilby wins German approval for chronic back pain; phase‑3 showed 1.9 vs 1.4 pain reduction, 17% discontinued; launch planned Sept 2026.
State-licensed medical cannabis products are increasingly becoming available to patients across various states, with new regulations and legislative changes facilitating…
Ahead of European Cannabis Week, Pierre van Weperen, Managing Director of Grow Group, discusses the current state and future of…
Shaun Deane, a 28-year-old from Plymouth, has shared his journey with Crohn’s disease, a chronic inflammatory bowel condition that he…
NuggMD, a trusted telemedicine platform, has announced a nationwide expansion of its services, now catering to all eligible medical cannabis…
As the availability of medicinal cannabis increases across the United Kingdom, there is growing concern regarding its safe storage, especially…